Introduction {#S0001}
============

Acute renal failure (ARF) requiring the use of renal replacement therapy (RRT) is a rare, but very severe complication of cardiac surgery. It is a sudden renal insufficiency accompanied by higher creatinine blood level and oliguria, defined as urine output \< 0.5 ml/kg per hour. Its incidence varies from 2% to 15% with overall mortality as high as 40% to 80%, highlighting the importance of this issue \[[@CIT0001], [@CIT0002]\]. Moreover, ARF has been proven to be an independent predictor of death after cardiac surgery \[[@CIT0003]\]. One of the main problems faced by physicians in everyday practice is a lack of consensus on the diagnostic criteria for ARF and the optimal time to initiate RRT. In this study ARF was considered in the case of oliguria or if there was a clinical need for RRT initiation (e.g. uncontrollable hyperkalaemia).

The aim of our study was to find differences between two observed groups of patients, who underwent dialysis as a treatment for ARF after cardiac surgery: those who died during treatment (group 1) and those who survived until hospital discharge (group 2). Modifiable and unmodifiable factors connected with heart operation were analysed in order to find predictors of mortality in the examined population.

Material and methods {#S0002}
====================

The retrospective analysis included 45 patients diagnosed with ARF after cardiac surgery and subsequently treated with RRT in our clinic in years 2009 to 2013. Data was obtained from patients' records as well as the hospital\'s cardiac surgery database.

Collected information was divided into three categories:Preoperative factors: patient\'s sex, age, weight, height, body mass index (BMI), ejection fraction (EF), EuroSCORE value, creatinine blood level, estimated glomerular filtration rate (eGFR) on admission, recent myocardial infarction (≤ 90 days before surgery) or angiography procedure (≤ 14 days before surgery), history of diabetes, hypertension, and heart failure.Factors associated with the surgery: procedure other than coronary artery bypass graft surgery (CABG), reoperation, concomitant surgery (e.g. CABG plus aortic valve replacement), use of extracorporeal circulation (ECC), time of ECC, time of cross clamp, and use of catecholamines and intra-aortic balloon pump (IABP) during surgeryPostoperative factors: respiratory support (\> 4 days after surgery), drainage (\> 1000 ml/24 h), day of RRT initiation, creatinine, urea and potassium blood levels at RRT initiation, bacteremia and maximal C-reactive protein (CRP) level, and administration of catecholamines and IABP in the postoperative period.

Statistical analysis was performed by Stat-Soft, Inc. STATISTICA (data analysis software system) version 12.0, using χ^2^ test, *t*-test, and *U* Mann-Whitney test.

Results {#S0003}
=======

In total 1.25% of patients treated in our clinic in years 2009-2013 (45 out of 3590 patients) developed ARF requiring RRT after cardiac surgery. Twenty-three (51.11%) died before discharge. As shown in [Table I](#T0001){ref-type="table"}, patients who died during treatment (group 1) were older and had higher mean BMI value than those who survived until discharge. Before the operation patients in group 1 had lower mean ejection fraction (EF) value; in this group we also observed higher percentage of patients diagnosed with heart failure, hypertension, or recent (≤ 90 days before surgery) myocardial infarction and higher percentage of angiography procedures (≤ 14 days before surgery). Surprisingly, patients in group 1 showed lower mean creatinine blood level values. However, none of those findings proved to be of statistical significance. After the statistical analysis the only significant preoperative death risk factor proved to be high score on the EuroSCORE scale, with a mean value of 9.28 in group 1 (survivors) vs. 7.15 in group 2 (*p* \< 0.05).

###### 

Preoperative, perioperative and postoperative data in groups 1 and 2

                                                                                              Group 1 (non-survivors) *n* = 23   Group 2 (survivors) *n* = 22   *p* value
  ------------------------------------------------------------------------------------------- ---------------------------------- ------------------------------ ------------------------------------------
  Preoperative factors                                                                                                                                          
   Age (years)[a](#TF0002){ref-type="table-fn"}                                               70.21                              67                             0.3473
   BMI[a](#TF0002){ref-type="table-fn"}                                                       28.22                              26.49                          0.2808
   Recent myocardial infarction (≤ 90 days before surgery)[b](#TF0003){ref-type="table-fn"}   47.83%                             31.81%                         0.2732
   Blood creatinine level on admission \[mg/dl\][a](#TF0002){ref-type="table-fn"}             1.526                              2.20                           0.2644
   EGFR on admission[a](#TF0002){ref-type="table-fn"}                                         59.72                              59.17                          0.9251
   Diabetes[b](#TF0003){ref-type="table-fn"}                                                  39.13%                             45.45%                         0.6676
   Hypertension[b](#TF0003){ref-type="table-fn"}                                              86.95%                             85.71%                         0.9045
   Heart failure[b](#TF0003){ref-type="table-fn"}                                             59.09%                             47.61%                         0.4509
   Ejection fraction (EF)[a](#TF0002){ref-type="table-fn"}                                    48.75                              51.2                           0.5709
   Angiography (≤ 14 days before surgery)[b](#TF0003){ref-type="table-fn"}                    45%                                42.85%                         0.8901
   EuroSCORE[a](#TF0002){ref-type="table-fn"}                                                 9.28                               7.15                           0.0422[\*](#TF0001){ref-type="table-fn"}
  Factors associated with the procedure                                                                                                                         
   Procedure other than CABG[b](#TF0003){ref-type="table-fn"}                                 63.63%                             40.9%                          0.1312
   Reoperation[b](#TF0003){ref-type="table-fn"}                                               27.27%                             23.85%                         0.7947
   Concomitant surgery[b](#TF0003){ref-type="table-fn"}                                       63.63%                             28.57%                         0.0212[\*](#TF0001){ref-type="table-fn"}
   Use of ECC[b](#TF0003){ref-type="table-fn"}                                                86.95%                             76.19%                         0.3550
   Time of ECC \[min\][a](#TF0002){ref-type="table-fn"}                                       147.9                              127.56                         0.3727
   Time of cross clamp \[min\][a](#TF0002){ref-type="table-fn"}                               81                                 70.66                          0.6769
   Catecholamines (in OR)[b](#TF0003){ref-type="table-fn"}                                    26.08%                             33.33%                         0.5987
   IABP (in OR)[b](#TF0003){ref-type="table-fn"}                                              17.39%                             20%                            0.8265
  Postoperative factors                                                                                                                                         
   Respiratory support (\> 4 days)                                                            68.18%                             52.38%                         0.2895
   Drainage (\> 1000 ml/24 h)[b](#TF0003){ref-type="table-fn"}                                54.54%                             45%                            0.5366
   Day of RRT initiation (after surgery)[a](#TF0002){ref-type="table-fn"}                     4.5                                5.47                           0.8554
   Blood creatinine level \[mg/dl\][a](#TF0002){ref-type="table-fn"}                          3.36                               3.84                           0.2281
   Blood urea level \[mg/dl\][a](#TF0002){ref-type="table-fn"}                                156.65                             102.54                         0.0305[\*](#TF0001){ref-type="table-fn"}
   Blood potassium level at RRT initiation \[mmol/l\][a](#TF0002){ref-type="table-fn"}        4.76                               4.87                           0.7388
   Bacteraemia[b](#TF0003){ref-type="table-fn"}                                               19%                                11.11%                         0.4935
   Maximal CRP level \[mg/l\][a](#TF0002){ref-type="table-fn"}                                198.77                             148.15                         0.1891
   Catecholamines (postoperative)[b](#TF0003){ref-type="table-fn"}                            100%                               68.42%                         0.0043[\*](#TF0001){ref-type="table-fn"}
   IABP (postoperative)[b](#TF0003){ref-type="table-fn"}                                      27.27%                             21.05%                         0.6437

Denotes statistical significance.

Mean value in the analysed group of patients

Percentage of patients in the analysed group

BMI -- body mass index, eGFR -- estimated glomerular filtration rate, CABG -- coronary artery bypass graft, ECC -- extracorporeal circulation, OR -- operating room, IABP -- intra-aortic balloon pump, RRT -- renal replacement therapy, CRP -- C reactive protein

When it comes to factors associated with the surgery, only the higher percentage of concomitant cardiac surgeries (e.g. CABG and concomitant aortic valve replacement) in group 1 (63.63% vs. 28.57%) turned out to be a statistically significant death predictor (*p* \< 0.05). Patients in group 1 were more often reoperated, had procedure other than CABG, and a higher percentage of surgeries in extracorporeal circulation (ECC). In this group the time of ECC and the cross clamp time were also longer. Administration of catecholamines and use of IABP during the operation were less frequent in group 1.

In the category of postoperative factors, admission of catecholamines (postop.) (100% vs. 68.42%) (*p* \< 0.005) and higher blood urea values at RRT initiation (156.65 mg/dl vs. 102.54 mg/dl) (*p* \< 0.05) proved to be statistically significant death predictors. A higher percentage of patients in group 1 required administration of catecholamines (postop.), IABP (postop.), respiratory support (\> 4 days), and drainage \> 1000 ml/24 h. They showed higher incidence of bacteraemia and higher maximal CRP levels. Surprisingly, in group 1, RRT was started earlier (4.5 vs. 5.47 day) with lower mean blood levels of urea, creatinine, and potassium prior to its initiation ([Table I](#T0001){ref-type="table"}).

Discussion {#S0004}
==========

Although there are many studies that have focused on the problem of ARF after cardiac surgery, there is still no consensus on a clear definition or precise pathophysiological mechanisms, risk factors, and practical guidelines concerning ARF patients, which in turn leads to poor outcomes.

Prerenal acute kidney insufficiency is caused by a decline in renal blood flow. It is not connected with disturbance of kidneys themselves, as in the case of renal ARF. Hypoperfusion of renal medulla, caused by vasoconstriction of renal arterioles and redistribution of blood flow within kidneys, seems to be the most likely mechanism leading to postoperative ARF. Therefore, if rapid and effective treatment reinforcing renal blood flow is undertaken the filtration will increase as well as the urine output. That is why fast diagnosis and treatment is of utmost importance to avoid ARF \[[@CIT0004]--[@CIT0006]\].

Nowadays, patients with acute kidney injury are often ordinated with RRT only after significant disturbance of acid-alkaline balance. The tendency is to delay the process of dialysis as long as the imbalance does not occur in order to avoid side effects of RRT. The presentation of AKI is connected with individual predisposition \[[@CIT0007]\].

There is a high number of risk factors mentioned in literature, suggested to provoke ARF after heart surgery, including: age \[[@CIT0008]\], diabetes \[[@CIT0009]--[@CIT0012]\], previous cardiovascular surgery \[[@CIT0004]\], CPB time \[[@CIT0013]\], duration of cross-clamp time \[[@CIT0014]\], generalised inflammatory response as a consequence of the CPB circuit \[[@CIT0015]\], and exposure to iodine dye (coronarography) a short time before surgery \[[@CIT0016]\]. However, analysis of those variables did not change any statistically important differences between group 1 and 2.

On the other hand, EuroSCORE or the need of vasopressor support after surgery \[[@CIT0017]\] proved to be statistically meaningful mortality predictors in the group of patients treated with RRT. However, those factors are generally associated with higher death risk in all patients undergoing surgery, not peculiarly those diagnosed with ARF.

Surprisingly, there was a relevant difference in urea level at RRT initiation without a significant discrepancy in creatinine level. Therefore, level of urea should not be underestimated or omitted when creatinine level is within normal limits. Also, the fact of undergoing a concomitant surgery turned out to be a statistically important factor affecting the patients' mortality rate. However, parameters such as CPB use, CPB time, or cross clamp time did not prove to be of statistical significance.

Limitations {#S0005}
===========

A relatively small group of patients and lack of follow-up observation after discharge (only short-term results) may have been limitations of our study.

Conclusions {#S0006}
===========

Statistically significant death predictors in the group of patients treated with RRT because of acute kidney insufficiency that occurred after cardiac surgery turned out to be: high EuroSCORE, concomitant surgery, high urea level at RRT initiation, and admission of catecholamines in the postoperative period. The presented observations should be further investigated on a larger group of patients, followed by the creation of practical guidelines on the treatment of postoperative ARF and the place of renal replacement therapy within that process.
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